Travere Therapeutics (TVTX) Goodwill (2014 - 2025)
Travere Therapeutics (TVTX) posted Goodwill of $800000.0 for Q3 2025, little changed on a QoQ basis from $800000.0 in Q2 2025, and little changed year-over-year from $800000.0 in Q3 2024.
Travere Therapeutics (TVTX) Goodwill (2014 - 2025) Analysis & Trends
Travere Therapeutics' Goodwill history runs 12 years deep, the most recent figure standing at $800000.0 for Q3 2025.
- Quarterly Goodwill changed 0.0% year-over-year to $800000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $800000.0 (changed 0.0% YoY) and the FY2024 annual result came in at $800000.0, changed 0.0% from the prior year.
- Goodwill was $800000.0 for Q3 2025 at Travere Therapeutics, roughly flat from $800000.0 in the prior quarter.
- Across five years, Goodwill topped out at $936000.0 in Q1 2021 and bottomed at $800000.0 in Q4 2022.
- A 5-year average of $853052.6 and a median of $800000.0 in 2022 frame the typical range for Goodwill.
- Annual changes were most pronounced in 2021 — Goodwill changed 0.0% — and 2022, when it fell 11.11%.
- Travere Therapeutics' Goodwill stood at $900000.0 in 2021, then slipped by 11.11% to $800000.0 in 2022, then changed by 0.0% to $800000.0 in 2023, then changed by 0.0% to $800000.0 in 2024, then changed by 0.0% to $800000.0 in 2025.
- Business Quant data shows TVTX's Goodwill at $800000.0 in Q3 2025, $800000.0 in Q2 2025, and $800000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Travere Therapeutics | 5.21 Bn | 5.21 Bn | 125.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 800,000.00 |
| Jun 30, 2025 | 800,000.00 |
| Mar 31, 2025 | 800,000.00 |
| Dec 31, 2024 | 800,000.00 |
| Sep 30, 2024 | 800,000.00 |
| Jun 30, 2024 | 800,000.00 |
| Mar 31, 2024 | 800,000.00 |
| Dec 31, 2023 | 800,000.00 |
| Sep 30, 2023 | 800,000.00 |
| Jun 30, 2023 | 900,000.00 |
| Mar 31, 2023 | 900,000.00 |
| Dec 31, 2022 | 800,000.00 |
| Sep 30, 2022 | 900,000.00 |
| Jun 30, 2022 | 900,000.00 |
| Mar 31, 2022 | 900,000.00 |
| Dec 31, 2021 | 900,000.00 |
| Sep 30, 2021 | 936,000.00 |
| Jun 30, 2021 | 936,000.00 |
| Mar 31, 2021 | 936,000.00 |
| Dec 31, 2020 | 900,000.00 |